human il 1ra Search Results


94
R&D Systems il 1ra protein
Il 1ra Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 1ra protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
il 1ra protein - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
R&D Systems human il 1ra quantikine immunoassay
Human Il 1ra Quantikine Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 1ra quantikine immunoassay/product/R&D Systems
Average 90 stars, based on 1 article reviews
human il 1ra quantikine immunoassay - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

95
R&D Systems il1rn
Il1rn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il1rn/product/R&D Systems
Average 95 stars, based on 1 article reviews
il1rn - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

94
R&D Systems human il 1 receptor inhibitor
KEY RESOURCES TABLE
Human Il 1 Receptor Inhibitor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 1 receptor inhibitor/product/R&D Systems
Average 94 stars, based on 1 article reviews
human il 1 receptor inhibitor - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
R&D Systems dy280
KEY RESOURCES TABLE
Dy280, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dy280/product/R&D Systems
Average 94 stars, based on 1 article reviews
dy280 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
R&D Systems goat igg anti il 1ra
KEY RESOURCES TABLE
Goat Igg Anti Il 1ra, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat igg anti il 1ra/product/R&D Systems
Average 94 stars, based on 1 article reviews
goat igg anti il 1ra - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
R&D Systems anti human il 1ra antibody
Association between <t>IL-1Ra</t> genotype and the monocyte production of IL-1Ra in response to M . tuberculosis and PPD. The amount of IL-1Ra produced by PBMCs from healthy, PPD-nonreactive donors during a 10-h coculture with either M . tuberculosis (A) or PPD (B) was determined by ELISA. Values were normalized to the number of monocytes present in the culture. The response of IL-1Ra A2 + individuals was higher at all doses of either stimuli.
Anti Human Il 1ra Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human il 1ra antibody/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti human il 1ra antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
R&D Systems normal upper limit 2 il 1β biosource ahc0013 pierce endogen m420b b r d systems 201 lb
Association between <t>IL-1Ra</t> genotype and the monocyte production of IL-1Ra in response to M . tuberculosis and PPD. The amount of IL-1Ra produced by PBMCs from healthy, PPD-nonreactive donors during a 10-h coculture with either M . tuberculosis (A) or PPD (B) was determined by ELISA. Values were normalized to the number of monocytes present in the culture. The response of IL-1Ra A2 + individuals was higher at all doses of either stimuli.
Normal Upper Limit 2 Il 1β Biosource Ahc0013 Pierce Endogen M420b B R D Systems 201 Lb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal upper limit 2 il 1β biosource ahc0013 pierce endogen m420b b r d systems 201 lb/product/R&D Systems
Average 90 stars, based on 1 article reviews
normal upper limit 2 il 1β biosource ahc0013 pierce endogen m420b b r d systems 201 lb - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
R&D Systems capture antibody rat anti murine il1rn
Comparison of therapeutic efficacy using Saa3 versus IL1E/IL6P promoter for disease-regulated <t>Il1rn</t> expression. (a) Promoter activity in transduced synovium of naive and arthritic C57Bl/6 mice. Knee joints were injected with 300 ng p24gag equivalent lentivirus encoding PGK, Saa3, or IL1E/IL6P-luciferase. Seven days after transduction, arthritis was induced by intra-articular injection of 180 µg zymosan A. After 24 hours, luciferase activity was assessed ex vivo. Data are represented as individual relative luciferase activities; horizontal bars indicate the means per group. (b) Efficacy of transcriptionally targeted adenoviral vectors expressing Il1rn. NIH-3T3-5xNF-κB-Luc were transduced at a multiplicity of infection (MOI) of 10 with control vector (del) or adenovirus encoding CMV, Saa3, and IL1E/IL6P-driven Il1rn. After 24 hours, cells were transduced at an MOI of 10 with control vector (del) or Ad5.CMV-Il1b. The day thereafter, IL-1β-induced NF-κB activation was assessed by luciferase assay. Data are represented as relative luciferase activities ± SEM (n = 4), and differences were determined using analysis of variance with Dunnett's post-test. **P < 0.01.
Capture Antibody Rat Anti Murine Il1rn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/capture antibody rat anti murine il1rn/product/R&D Systems
Average 90 stars, based on 1 article reviews
capture antibody rat anti murine il1rn - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
R&D Systems human il1ra
Comparison of therapeutic efficacy using Saa3 versus IL1E/IL6P promoter for disease-regulated <t>Il1rn</t> expression. (a) Promoter activity in transduced synovium of naive and arthritic C57Bl/6 mice. Knee joints were injected with 300 ng p24gag equivalent lentivirus encoding PGK, Saa3, or IL1E/IL6P-luciferase. Seven days after transduction, arthritis was induced by intra-articular injection of 180 µg zymosan A. After 24 hours, luciferase activity was assessed ex vivo. Data are represented as individual relative luciferase activities; horizontal bars indicate the means per group. (b) Efficacy of transcriptionally targeted adenoviral vectors expressing Il1rn. NIH-3T3-5xNF-κB-Luc were transduced at a multiplicity of infection (MOI) of 10 with control vector (del) or adenovirus encoding CMV, Saa3, and IL1E/IL6P-driven Il1rn. After 24 hours, cells were transduced at an MOI of 10 with control vector (del) or Ad5.CMV-Il1b. The day thereafter, IL-1β-induced NF-κB activation was assessed by luciferase assay. Data are represented as relative luciferase activities ± SEM (n = 4), and differences were determined using analysis of variance with Dunnett's post-test. **P < 0.01.
Human Il1ra, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il1ra/product/R&D Systems
Average 90 stars, based on 1 article reviews
human il1ra - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Boster Bio il 1ra
Comparison of therapeutic efficacy using Saa3 versus IL1E/IL6P promoter for disease-regulated <t>Il1rn</t> expression. (a) Promoter activity in transduced synovium of naive and arthritic C57Bl/6 mice. Knee joints were injected with 300 ng p24gag equivalent lentivirus encoding PGK, Saa3, or IL1E/IL6P-luciferase. Seven days after transduction, arthritis was induced by intra-articular injection of 180 µg zymosan A. After 24 hours, luciferase activity was assessed ex vivo. Data are represented as individual relative luciferase activities; horizontal bars indicate the means per group. (b) Efficacy of transcriptionally targeted adenoviral vectors expressing Il1rn. NIH-3T3-5xNF-κB-Luc were transduced at a multiplicity of infection (MOI) of 10 with control vector (del) or adenovirus encoding CMV, Saa3, and IL1E/IL6P-driven Il1rn. After 24 hours, cells were transduced at an MOI of 10 with control vector (del) or Ad5.CMV-Il1b. The day thereafter, IL-1β-induced NF-κB activation was assessed by luciferase assay. Data are represented as relative luciferase activities ± SEM (n = 4), and differences were determined using analysis of variance with Dunnett's post-test. **P < 0.01.
Il 1ra, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 1ra/product/Boster Bio
Average 90 stars, based on 1 article reviews
il 1ra - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

94
R&D Systems il 1ra
MECs alter their cytokine and chemokine secretion profile upon uptake of apoptotic bodies. (A) Ben-Men-I cells were treated with PMA, LPS, and left untreated or were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:5 for 24 h. Cell culture supernatants were analyzed for 36 different cytokines and chemokines using an antibody array. The array is organized in five rows (A-E) and 10 columns (1-10) with two spots for each analyte (R = positive control, N = negative control). Please note that spots corresponding to IL-1 receptor antagonist (marked with %) were weak but distinguishable to the eye. Differences in cytokine secretion between control and treatment groups are depicted in qualitative heat maps. (B) Ben-Men-I cells were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:1 or 1:5 for 24 h and the concentration of IL-6 in culture supernatant was measured by ELISA. IL-6 was measured in supernatant of apoptotic cells and subtracted as background from MECs treated with apoptotic cells. Shown is the average of three independent experiments with the error bars representing SD. Statistical significance was assessed using Student’s t -test (* P <0.05). Ben-Men-I cells were treated as in (B) and with concentrations of (C) IL-8, (D) Il-16, (E) CXCL1, (F) MIF (# represents P = 0.067), and (G) IL-1 receptor antagonist were measured by ELISA. Shown is the average of three independent experiments with the error bars representing SD. Statistical significance was analyzed by one-way ANOVA. P values were determined using pair-wise Student’s t -test adjusted according to Holm (# P <0.1; * P <0.05; ** P <0.01; *** P <0.001). Marked are the comparisons between the control (1:0) and treatment groups.
Il 1ra, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 1ra/product/R&D Systems
Average 94 stars, based on 1 article reviews
il 1ra - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone

doi: 10.1016/j.celrep.2023.113423

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: A beveled glass needle was pre-loaded with mineral oil and the recombinant human IL-1 receptor inhibitor (IL-1RA, R&D Systems, Cat #280-RA, resuspended in 0.1% BSA), then positioned in the injecting rig at a 90° angle relative to the horizontal plane of the Petri dish and head mold.

Techniques: Recombinant, Marker, In Situ, RNA Sequencing, Knock-Out, Mutagenesis, Real-time Polymerase Chain Reaction, Software

Association between IL-1Ra genotype and the monocyte production of IL-1Ra in response to M . tuberculosis and PPD. The amount of IL-1Ra produced by PBMCs from healthy, PPD-nonreactive donors during a 10-h coculture with either M . tuberculosis (A) or PPD (B) was determined by ELISA. Values were normalized to the number of monocytes present in the culture. The response of IL-1Ra A2 + individuals was higher at all doses of either stimuli.

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: Association between IL-1Ra genotype and the monocyte production of IL-1Ra in response to M . tuberculosis and PPD. The amount of IL-1Ra produced by PBMCs from healthy, PPD-nonreactive donors during a 10-h coculture with either M . tuberculosis (A) or PPD (B) was determined by ELISA. Values were normalized to the number of monocytes present in the culture. The response of IL-1Ra A2 + individuals was higher at all doses of either stimuli.

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques: Produced, Enzyme-linked Immunosorbent Assay

Relationship between polymorphism in IL-1Ra and the IL-1Ra/IL-1β ratio. The IL-1β content of the supernates shown in Fig. was also assayed by ELISA. The molar ratio of IL-1Ra/IL-1β was calculated. This ratio is selectively increased in IL-1Ra A2 + individuals in response to PPD and M . tuberculosis , accentuated by the finding that IL-1Ra A2 + subjects tended to produce less IL-1β in response to M . tuberculosis . By comparison, the ratio in response to LPS was not different between IL-1Ra A2 + and A2 − subjects. Response to PPD is data from eight individuals.

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: Relationship between polymorphism in IL-1Ra and the IL-1Ra/IL-1β ratio. The IL-1β content of the supernates shown in Fig. was also assayed by ELISA. The molar ratio of IL-1Ra/IL-1β was calculated. This ratio is selectively increased in IL-1Ra A2 + individuals in response to PPD and M . tuberculosis , accentuated by the finding that IL-1Ra A2 + subjects tended to produce less IL-1β in response to M . tuberculosis . By comparison, the ratio in response to LPS was not different between IL-1Ra A2 + and A2 − subjects. Response to PPD is data from eight individuals.

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques: Enzyme-linked Immunosorbent Assay, Comparison

Mean Fold Induction of the IL-1Rα and IL-1β Genes in Response to M. tuberculosis

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: Mean Fold Induction of the IL-1Rα and IL-1β Genes in Response to M. tuberculosis

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques:

(A) Effect of IL-6 and IL-10 on the IL-1Ra/IL-1β ratio. PBMCs were cultured with M . tuberculosis in the presence or absence of rhIL-6 or rhIL-10 over a dose range of 0.1–10 ng/ml. Culture supernates were assayed for IL-1Ra and IL-1β and the molar ratio calculated. IL-10 increased the ratio significantly even at the lowest dose ( P < 0.02), whereas rhIL-6 had no significant effect. (B) Effect of IFN-γ and IL-4 on the IL-1Ra/IL-1β ratio. PBMCs were cultured with M . tuberculosis in the presence or absence of rhIFN-γ or rhIL-4 over a dose range of 0.1–10 ng/ml. Culture supernates were assayed for IL-1Ra and IL-1β and the molar ratio calculated. IL-4 increased the ratio markedly even at the lowest dose ( P < 0.01), whereas higher doses of IFN-γ were required to cause a significant reduction.

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: (A) Effect of IL-6 and IL-10 on the IL-1Ra/IL-1β ratio. PBMCs were cultured with M . tuberculosis in the presence or absence of rhIL-6 or rhIL-10 over a dose range of 0.1–10 ng/ml. Culture supernates were assayed for IL-1Ra and IL-1β and the molar ratio calculated. IL-10 increased the ratio significantly even at the lowest dose ( P < 0.02), whereas rhIL-6 had no significant effect. (B) Effect of IFN-γ and IL-4 on the IL-1Ra/IL-1β ratio. PBMCs were cultured with M . tuberculosis in the presence or absence of rhIFN-γ or rhIL-4 over a dose range of 0.1–10 ng/ml. Culture supernates were assayed for IL-1Ra and IL-1β and the molar ratio calculated. IL-4 increased the ratio markedly even at the lowest dose ( P < 0.01), whereas higher doses of IFN-γ were required to cause a significant reduction.

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques: Cell Culture

Lack of Relationship between  IL-1Ra  Polymorphism and the Intracellular Growth of M. tuberculosis In Vitro

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: Lack of Relationship between IL-1Ra Polymorphism and the Intracellular Growth of M. tuberculosis In Vitro

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques: Infection

 IL-1Ra  and IL-1β Allele and Genotype Frequencies in Tuberculosis Patients and Tuberculin-reactive Healthy Control Subjects

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: IL-1Ra and IL-1β Allele and Genotype Frequencies in Tuberculosis Patients and Tuberculin-reactive Healthy Control Subjects

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques: Control

Relationship between  IL-1Ra/IL-1β  Haplotype and Disease Phenotype

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: Relationship between IL-1Ra/IL-1β Haplotype and Disease Phenotype

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques:

Association between IL-1Ra haplotype and the cutaneous response to PPD of M . tuberculosis . The mean diameter of induration in response to one tuberculin unit of PPD in tuberculosis patients of various genotypes is shown. The proportion of IL-1Ra A2 + was highest (60%) in patients with an absent response and lowest in the category 21–30 mm (25%), falling gradually to its overall frequency (41%) as successively higher grades of Mantoux were considered.

Journal: The Journal of Experimental Medicine

Article Title: Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

doi:

Figure Lengend Snippet: Association between IL-1Ra haplotype and the cutaneous response to PPD of M . tuberculosis . The mean diameter of induration in response to one tuberculin unit of PPD in tuberculosis patients of various genotypes is shown. The proportion of IL-1Ra A2 + was highest (60%) in patients with an absent response and lowest in the category 21–30 mm (25%), falling gradually to its overall frequency (41%) as successively higher grades of Mantoux were considered.

Article Snippet: After washing (×4), 100 μl of the following biotinylated detection antibodies were added in diluent (0.1% BSA, 0.05% Tween 20 in TBS, pH 7.3): 100 ng/ml anti–human IL-1β antibody or 20 ng/ml anti–human IL-1Ra antibody (both from R & D Systems, Inc.).

Techniques:

Comparison of therapeutic efficacy using Saa3 versus IL1E/IL6P promoter for disease-regulated Il1rn expression. (a) Promoter activity in transduced synovium of naive and arthritic C57Bl/6 mice. Knee joints were injected with 300 ng p24gag equivalent lentivirus encoding PGK, Saa3, or IL1E/IL6P-luciferase. Seven days after transduction, arthritis was induced by intra-articular injection of 180 µg zymosan A. After 24 hours, luciferase activity was assessed ex vivo. Data are represented as individual relative luciferase activities; horizontal bars indicate the means per group. (b) Efficacy of transcriptionally targeted adenoviral vectors expressing Il1rn. NIH-3T3-5xNF-κB-Luc were transduced at a multiplicity of infection (MOI) of 10 with control vector (del) or adenovirus encoding CMV, Saa3, and IL1E/IL6P-driven Il1rn. After 24 hours, cells were transduced at an MOI of 10 with control vector (del) or Ad5.CMV-Il1b. The day thereafter, IL-1β-induced NF-κB activation was assessed by luciferase assay. Data are represented as relative luciferase activities ± SEM (n = 4), and differences were determined using analysis of variance with Dunnett's post-test. **P < 0.01.

Journal:

Article Title: Computational Design and Application of Endogenous Promoters for Transcriptionally Targeted Gene Therapy for Rheumatoid Arthritis

doi: 10.1038/mt.2009.182

Figure Lengend Snippet: Comparison of therapeutic efficacy using Saa3 versus IL1E/IL6P promoter for disease-regulated Il1rn expression. (a) Promoter activity in transduced synovium of naive and arthritic C57Bl/6 mice. Knee joints were injected with 300 ng p24gag equivalent lentivirus encoding PGK, Saa3, or IL1E/IL6P-luciferase. Seven days after transduction, arthritis was induced by intra-articular injection of 180 µg zymosan A. After 24 hours, luciferase activity was assessed ex vivo. Data are represented as individual relative luciferase activities; horizontal bars indicate the means per group. (b) Efficacy of transcriptionally targeted adenoviral vectors expressing Il1rn. NIH-3T3-5xNF-κB-Luc were transduced at a multiplicity of infection (MOI) of 10 with control vector (del) or adenovirus encoding CMV, Saa3, and IL1E/IL6P-driven Il1rn. After 24 hours, cells were transduced at an MOI of 10 with control vector (del) or Ad5.CMV-Il1b. The day thereafter, IL-1β-induced NF-κB activation was assessed by luciferase assay. Data are represented as relative luciferase activities ± SEM (n = 4), and differences were determined using analysis of variance with Dunnett's post-test. **P < 0.01.

Article Snippet: White high-binding flat bottom 96-well plates (Greiner Bio-One, Alphen a/d Rijn, the Netherlands) were coated with the capture antibody rat anti-murine Il1rn (MAB480; R&D Systems, Minneapolis, MN) at 3 μg/ml in 0.1 mol/l carbonate buffer pH 9.6 and incubated overnight at 4 °C.

Techniques: Comparison, Drug discovery, Expressing, Activity Assay, Injection, Luciferase, Transduction, Ex Vivo, Infection, Control, Plasmid Preparation, Activation Assay

MECs alter their cytokine and chemokine secretion profile upon uptake of apoptotic bodies. (A) Ben-Men-I cells were treated with PMA, LPS, and left untreated or were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:5 for 24 h. Cell culture supernatants were analyzed for 36 different cytokines and chemokines using an antibody array. The array is organized in five rows (A-E) and 10 columns (1-10) with two spots for each analyte (R = positive control, N = negative control). Please note that spots corresponding to IL-1 receptor antagonist (marked with %) were weak but distinguishable to the eye. Differences in cytokine secretion between control and treatment groups are depicted in qualitative heat maps. (B) Ben-Men-I cells were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:1 or 1:5 for 24 h and the concentration of IL-6 in culture supernatant was measured by ELISA. IL-6 was measured in supernatant of apoptotic cells and subtracted as background from MECs treated with apoptotic cells. Shown is the average of three independent experiments with the error bars representing SD. Statistical significance was assessed using Student’s t -test (* P <0.05). Ben-Men-I cells were treated as in (B) and with concentrations of (C) IL-8, (D) Il-16, (E) CXCL1, (F) MIF (# represents P = 0.067), and (G) IL-1 receptor antagonist were measured by ELISA. Shown is the average of three independent experiments with the error bars representing SD. Statistical significance was analyzed by one-way ANOVA. P values were determined using pair-wise Student’s t -test adjusted according to Holm (# P <0.1; * P <0.05; ** P <0.01; *** P <0.001). Marked are the comparisons between the control (1:0) and treatment groups.

Journal: Journal of Neuroinflammation

Article Title: Anti-inflammatory response following uptake of apoptotic bodies by meningothelial cells

doi: 10.1186/1742-2094-11-35

Figure Lengend Snippet: MECs alter their cytokine and chemokine secretion profile upon uptake of apoptotic bodies. (A) Ben-Men-I cells were treated with PMA, LPS, and left untreated or were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:5 for 24 h. Cell culture supernatants were analyzed for 36 different cytokines and chemokines using an antibody array. The array is organized in five rows (A-E) and 10 columns (1-10) with two spots for each analyte (R = positive control, N = negative control). Please note that spots corresponding to IL-1 receptor antagonist (marked with %) were weak but distinguishable to the eye. Differences in cytokine secretion between control and treatment groups are depicted in qualitative heat maps. (B) Ben-Men-I cells were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:1 or 1:5 for 24 h and the concentration of IL-6 in culture supernatant was measured by ELISA. IL-6 was measured in supernatant of apoptotic cells and subtracted as background from MECs treated with apoptotic cells. Shown is the average of three independent experiments with the error bars representing SD. Statistical significance was assessed using Student’s t -test (* P <0.05). Ben-Men-I cells were treated as in (B) and with concentrations of (C) IL-8, (D) Il-16, (E) CXCL1, (F) MIF (# represents P = 0.067), and (G) IL-1 receptor antagonist were measured by ELISA. Shown is the average of three independent experiments with the error bars representing SD. Statistical significance was analyzed by one-way ANOVA. P values were determined using pair-wise Student’s t -test adjusted according to Holm (# P <0.1; * P <0.05; ** P <0.01; *** P <0.001). Marked are the comparisons between the control (1:0) and treatment groups.

Article Snippet: After 24 h, the culture supernatants were harvested, centrifuged at 1,000 rpm for 5 min, and assayed for IL-6, IL-8 (Orgenium Laboratories), IL-1RA (R&D, DRA00B), IL-16 (RayBiotech, ELH-IL16-001), MIF (RayBiotech, ELH-MIF-001), or CXCL1 (R&D, DRG00) by ELISA.

Techniques: Incubation, Cell Culture, Ab Array, Positive Control, Negative Control, Concentration Assay, Enzyme-linked Immunosorbent Assay